Journal Club: Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation

While I’m catching up on journal club reading, two weeks ago we discussed Chu et al, Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation, which takes on the question of how to decide when it is safe to stop a massive disease elimination program.  This work must rely on some cool mathematical epi modeling, to say how many years of what level of coverage is necessary before you can hope the LF is gone.

Comments Off on Journal Club: Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation

Filed under disease modeling, global health

Comments are closed.